E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation

BACKGROUND: E2F1 is the gatekeeper of the cell cycle controlling an analogous balance between proliferation and cell death. E2F1 expression is elevated in advanced prostate cancer. However, it is still unclear that the roles and mechanisms of E2F1 on prostate cancers. METHODS: Targeted knockdown by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zijia, Kang, Wenyao, Wang, Lihua, Sun, Baoliang, Ma, Jiajia, Zheng, Chaogu, Sun, Jie, Tian, Zhigang, Yang, Xiaoyi, Xiao, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004456/
https://www.ncbi.nlm.nih.gov/pubmed/24742333
http://dx.doi.org/10.1186/1476-4598-13-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004456/
https://www.ncbi.nlm.nih.gov/pubmed/24742333
http://dx.doi.org/10.1186/1476-4598-13-84

Ejemplares similares